Literature DB >> 18181809

The adsorption of vancomycin by polyacrylonitrile, polyamide, and polysulfone hemofilters.

Qi Tian1, Charles D Gomersall, Patricia P N Leung, Gordon Y S Choi, Gavin M Joynt, Perpetua E Tan, April S Y Wong.   

Abstract

The aim of this study was to characterize vancomycin adsorption by polyacrylonitrile (PAN), polyamide, and polysulfone hemofilters using an in vitro model of hemofiltration. Vancomycin (36 mg) was added to a blood-crystalloid mixture of known volume (target concentration of 50 mg/L) and pumped around a closed circuit. Adsorption, which was calculated from the fall in concentration over 120 min, was significantly greater by 0.6-m(2) PAN filters (10.08 +/- 2.26 mg) than by 0.6-m(2) polyamide (5.20 +/- 1.82 mg) or 0.7-m(2) polysulfone (4.80 +/- 2.40 mg) filters (P < 0.05). Cumulative adsorption was not changed by the addition of 500-mL lactated Ringer's solution (to reduce the circulating vancomycin concentration). These data show that although adsorption of vancomycin by PAN, polyamide, and polysulfone hemofilters occurs, the absolute adsorption is small. Adsorption is dependent on filter material and is not reversed by a decrease in circulating concentration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18181809     DOI: 10.1111/j.1525-1594.2007.00460.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  9 in total

1.  Effect of preexposure to aminoglycosides on in vitro adsorption of amikacin by polyacrylonitrile hemofilters.

Authors:  Q Tian; C D Gomersall; M Ip; G M Joynt
Journal:  Antimicrob Agents Chemother       Date:  2011-04-18       Impact factor: 5.191

2.  Reply to Baud and Houzé, "Should In Vitro and In Vivo Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General Principles of Pharmacokinetics?"

Authors:  E Wenzler; M Biagi; X Tan; D A Butler
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

3.  Should In Vitro and In Vivo Studies on Antimicrobial Agents during Continuous Renal Replacement Therapy Comply with General Principles of Pharmacokinetics?

Authors:  Frédéric J Baud; Pascal Houzé
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

4.  Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy.

Authors:  Deborah A Pasko; Mariann D Churchwell; Noha N Salama; Bruce A Mueller
Journal:  Blood Purif       Date:  2011-03-02       Impact factor: 2.614

5.  The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis.

Authors:  Alain Ficheux; Nathalie Gayrard; Ilan Szwarc; Daniel Andress; Stéphan Soullier; Yohan Duny; Gilles Goubert; Marie Thomas; Johanna Bismuth-Mondolfo; Jean-Pierre Daurès; Philippe Brunet; Marie-Françoise Servel; Angel Argilés
Journal:  Nephrol Dial Transplant       Date:  2010-12-10       Impact factor: 5.992

Review 6.  Treatment with echinocandins during continuous renal replacement therapy.

Authors:  Francisco González de Molina; Maria de Los Ángeles Martínez-Alberici; Ricard Ferrer
Journal:  Crit Care       Date:  2014-03-28       Impact factor: 9.097

7.  Comparison of adsorption of selected antibiotics on the filters in continuous renal replacement therapy circuits: in vitro studies.

Authors:  Dariusz Onichimowski; Hubert Ziółkowski; Krzysztof Nosek; Jerzy Jaroszewski; Elżbieta Rypulak; Mirosław Czuczwar
Journal:  J Artif Organs       Date:  2019-10-20       Impact factor: 1.731

8.  Adsorption of vancomycin, gentamycin, ciprofloxacin and tygecycline on the filters in continuous renal replacement therapy circuits: in full blood in vitro study.

Authors:  Dariusz Onichimowski; Krzysztof Nosek; Hubert Ziółkowski; Jerzy Jaroszewski; Aleksandra Pawlos; Mirosław Czuczwar
Journal:  J Artif Organs       Date:  2020-10-08       Impact factor: 1.731

9.  Membrane adsorption in vancomycin treatment is membrane type dependent in CVVHDF: dose correction is crucial.

Authors:  Patrick M Honore; Sebastien Redant; Pharan Djimafo; Thierry Preseau; Bogdan Vasile Cismas; Keitiane Kaefer; Leonel Barreto Gutierrez; Sami Anane; Rachid Attou; Andrea Gallerani; David De Bels
Journal:  Crit Care       Date:  2022-04-29       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.